3.1 Acute Respiratory Failure & ARDS Management

3.1 Acute Respiratory Failure & ARDS Management

Acute respiratory failure is one of the most critical diagnostic challenges encountered by the Acute Care Nurse Practitioner (ACNPC-AG). Rapid differentiation of failure phenotypes, timely recognition of Acute Respiratory Distress Syndrome (ARDS), and adherence to evidence-based lung-protective ventilation are essential to minimize ventilator-induced lung injury (VILI) and reduce mortality.

Classification: Type I vs. Type II Acute Respiratory Failure

Acute respiratory failure occurs when pulmonary gas exchange fails, producing life-threatening hypoxemia, hypercapnia, or both:

In true intrapulmonary shunt—such as non-aerated alveoli in ARDS—blood traverses capillary beds without gas exchange. Supplemental oxygen alone cannot correct shunt-induced hypoxemia; positive end-expiratory pressure (PEEP) is mandatory to recruit collapsed units.

Berlin Diagnostic Definition of ARDS

The Berlin Definition establishes four mandatory diagnostic criteria:

1. Timing: Onset within 1 week of a known clinical insult (sepsis, trauma, aspiration, pancreatitis) or new/worsening respiratory symptoms.
2. Chest Imaging: Bilateral opacities on chest radiography or CT not fully explained by pleural effusions, lobar collapse, or nodules.
3. Origin of Edema: Respiratory failure not fully explained by cardiac failure or fluid overload. Objective assessment (e.g., echocardiography demonstrating preserved ejection fraction and normal filling pressures) must rule out cardiogenic edema if no explicit risk factor is present.
4. Oxygenation Deficit (measured on $\text{PEEP} \ge 5\text{ cm H}_2\text{O}$):
   • Mild ARDS: $200 < \text{PaO}_2 / \text{FiO}_2 \le 300\text{ mmHg}$
   • Moderate ARDS: $100 < \text{PaO}_2 / \text{FiO}_2 \le 200\text{ mmHg}$
   • Severe ARDS: $\text{PaO}_2 / \text{FiO}_2 \le 100\text{ mmHg}$

ARDSnet Lung-Protective Mechanical Ventilation

The landmark ARDS Network (ARMA) trial showed that low tidal volume ventilation reduced mortality and increased ventilator-free days compared with traditional higher tidal volumes.

Predicted Body Weight (PBW) Calculation

Tidal volumes must always be calculated using Predicted Body Weight (PBW), as lung parenchymal volume correlates with height and biological sex, not adipose mass:

$\text{PBW (Males)} = 50 + 0.91 \times (\text{Height in cm} - 152.4) \quad \text{or} \quad 50 + 2.3 \times (\text{Height in inches} - 60)$ $\text{PBW (Females)} = 45.5 + 0.91 \times (\text{Height in cm} - 152.4) \quad \text{or} \quad 45.5 + 2.3 \times (\text{Height in inches} - 60)$

Operational Ventilation Targets

• Initial Tidal Volume: Start at $8\text{ mL/kg PBW}$, titrating down by $1\text{ mL/kg}$ every 2 hours to a target of $6\text{ mL/kg PBW}$ (acceptable range: $4\text{ to } 8\text{ mL/kg PBW}$).
• Plateau Pressure ($P_{\text{plat}}$): Measured during a $0.5\text{ second}$ end-inspiratory pause. Keep $P_{\text{plat}} \le 30\text{ cm H}_2\text{O}$. If $P_{\text{plat}} > 30\text{ cm H}_2\text{O}$, reduce tidal volume in $1\text{ mL/kg}$ decrements down to $4\text{ mL/kg PBW}$.
• Driving Pressure ($\Delta P$): Defined as Plateau Pressure minus PEEP ($\Delta P = P_{\text{plat}} - \text{PEEP}$). Driving pressure is the mechanical variable most tightly linked to hospital mortality; target $\Delta P < 15\text{ cm H}_2\text{O}$.
• Gas Exchange Goals: Maintain $\text{PaO}_2\ 55\text{--}80\text{ mmHg}$ or $\text{SpO}_2\ 88\%\text{--}95\%$. Permissive hypercapnia is accepted down to $\text{pH} \ge 7.20$ (or $\ge 7.15$ in refractory cases), provided elevated intracranial pressure is excluded.

Evidence-Based Adjunctive Therapies for Severe ARDS

When $\text{PaO}_2 / \text{FiO}_2 < 150\text{ mmHg}$ persists despite lung-protective ventilation and PEEP optimization, evidence-based adjuncts must be initiated:

1. Prone Positioning

The PROSEVA trial proved that prone positioning for at least 16 consecutive hours daily confers a profound mortality benefit in severe ARDS ($\text{PaO}_2/\text{FiO}_2 < 150\text{ mmHg}$ with $\text{FiO}_2 \ge 0.60$ and $\text{PEEP} \ge 5\text{ cm H}_2\text{O}$). Prone positioning homogenizes transpulmonary pressure gradients, recruits dorsal lung units, and unburdens dorsal parenchyma from cardiac and visceral compression. For patients on high-flow nasal cannula (HFNC), the ROX index ($[\text{SpO}_2/\text{FiO}_2]/\text{Respiratory Rate}$) helps assess failure risk. A value $<3.85$ at 12 hours prompts urgent reassessment; intubate for worsening hypoxemia, respiratory effort, mentation or hemodynamics rather than the score alone.

2. Neuromuscular Blockade

Early continuous infusion of cisatracurium besylate ($37.5\text{ mg/hr}$ or weight-adjusted) for up to 48 hours eliminates patient-ventilator dyssynchrony, lowers transpulmonary pressure swings, and suppresses "pendelluft" gas shifts between injured lung regions (ACURASYS trial). Per the ROSE trial, deep sedation and paralysis are prioritized for persistent dyssynchrony, high driving pressures, or refractory hypoxemia despite lung-protective ventilator titration.

3. High PEEP & Recruitment Maneuvers

For moderate-to-severe ARDS, consider higher PEEP without lung recruitment maneuvers, using a PEEP/FiO2 table and monitoring compliance, oxygenation and hemodynamics. Avoid prolonged high-pressure recruitment maneuvers: they can increase mortality, barotrauma and circulatory compromise. Do not routinely recruit the lung at high pressures before selecting PEEP.

4. Conservative Fluid Strategy

After shock resolves, a conservative fluid strategy can improve ventilator-free days. FACTT used low filling-pressure targets (CVP $<4$ or PAOP $<8$ mmHg) after hemodynamic stabilization; shock required resuscitation, and diuresis was withheld for 12 hours after the last fluid bolus or vasopressor. Do not pursue negative balance during active shock.

5. VV-ECMO Indications & Murray Scoring

Veno-venous ECMO provides rescue gas exchange in selected patients despite optimized lung-protective care. The Murray Lung Injury Score considers radiographic quadrants, P/F ratio, PEEP and respiratory-system compliance. EOLIA eligibility included P/F $<80$ mmHg for $>6$ hours, P/F $<50$ for $>3$ hours, or $pH<7.25$ with $PaCO_2\ge60$ mmHg for $>6$ hours despite optimization (including respiratory rate up to 35/min and plateau pressure $\le32$ cm H2O). These findings prompt early ECMO-center consultation and individualized selection.